دورية أكاديمية
Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review.
| العنوان: | Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review. |
|---|---|
| المؤلفون: | Yang W; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China., Hu D; Department of pharmacy, ZheJiang Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Zheng B; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Han B; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Feng P; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Zhou Y; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China.; Department of Psychiatry, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Wang W; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China.; Department of Psychiatry, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Li G; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China. ligonghua88@163.com.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China. ligonghua88@163.com., Zhang M; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China. zml9998@sina.com.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China. zml9998@sina.com. |
| المصدر: | BMC psychiatry [BMC Psychiatry] 2024 Jul 08; Vol. 24 (1), pp. 491. Date of Electronic Publication: 2024 Jul 08. |
| نوع المنشور: | Journal Article; Case Reports; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2001- |
| مواضيع طبية MeSH: | Lurasidone Hydrochloride*/adverse effects , Lurasidone Hydrochloride*/therapeutic use , Bipolar Disorder*/drug therapy , Antipsychotic Agents*/adverse effects , Antipsychotic Agents*/therapeutic use , Exanthema*/chemically induced, Humans ; Male ; Middle Aged ; East Asian People |
| مستخلص: | Background: Rash is one of common adverse drug reaction and which have been reported in typical and atypical antipsychotics. Reports of lurasidone induced skin reactions are sparse. In this study, we report a case of rash caused by lurasidone. Case Presentation: A 63-year-old man with bipolar disorder (BD) who is treated by lurasidone. However, the patient presents a rash all over after lurasidone dose increasing from 40 mg/day to 60 mg/day. With the diagnosis of drug induced rash, lurasidone was discontinued, and the rash complete disappears within 2 weeks. In addition, all case reports about antipsychotics associated rash were reviewed by searching English and Chinese database including Pubmed, Embase, Cochrane Library, CNKI and Wanfang database. A total of 139 articles contained 172 patients were included in our study. The literature review and our case suggest that the cutaneous adverse events caused by antipsychotic drugs should not be ignored, particularly for the patient who was first use or at dose increasing of antipsychotic. Conclusions: In conclusion, we report a case of lurasidone related rash and review rash caused by antipsychotics. Psychiatrists should be alert to the possibility of the rash caused by antipsychotics, especially the patient was first use of antipsychotics or the antipsychotic dose was increasing. (© 2024. The Author(s).) |
| References: | J Affect Disord. 2014 Feb;155:20-7. (PMID: 24246116) Chem Res Toxicol. 2023 Nov 20;36(11):1711-1716. (PMID: 37922508) JAMA. 2023 Aug 1;330(5):395-398. (PMID: 37440226) Front Psychiatry. 2022 Jul 29;13:953621. (PMID: 35966460) Cureus. 2023 Apr 24;15(4):e38071. (PMID: 37228542) J Affect Disord. 2023 Sep 15;337:150-158. (PMID: 37245552) Clin Pharmacol Ther. 2020 Dec;108(6):1233-1242. (PMID: 32627186) Rev Colomb Psiquiatr (Engl Ed). 2021 Jan 18;:. (PMID: 33735035) Asian J Psychiatr. 2023 Jul;85:103613. (PMID: 37163943) J Clin Psychiatry. 2023 Jun 7;84(4):. (PMID: 37339360) J Clin Pharmacol. 1992 Oct;32(10):897-904. (PMID: 1447396) Bipolar Disord. 2024 Feb;26(1):22-32. (PMID: 37463846) Lancet. 2020 Dec 5;396(10265):1841-1856. (PMID: 33278937) Bipolar Disord. 2018 Jun;20(4):391-392. (PMID: 29327794) Eur J Pharmacol. 2007 Oct 31;572(2-3):160-70. (PMID: 17662268) Int Clin Psychopharmacol. 2023 Jul 1;38(4):275-280. (PMID: 36853746) Med Clin North Am. 2023 Jan;107(1):31-60. (PMID: 36402499) Expert Opin Pharmacother. 2022 Nov;23(16):1801-1818. (PMID: 36398838) J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):485-488. (PMID: 35916577) Brain Sci. 2023 Apr 29;13(5):. (PMID: 37239213) Lancet Psychiatry. 2022 Feb;9(2):137-150. (PMID: 35026139) Drug Saf. 2008;31(1):21-37. (PMID: 18095744) Am J Med. 2011 Jul;124(7):588-97. (PMID: 21592453) Psychol Med. 2023 Jun;53(8):3377-3386. (PMID: 35256032) Am J Psychiatry. 2014 Feb;171(2):131-3. (PMID: 24170243) BMC Psychiatry. 2017 Nov 21;17(1):373. (PMID: 29162032) Prim Care Companion CNS Disord. 2019 Mar 28;21(2):. (PMID: 30947406) J Psychiatr Res. 2020 Jun;125:96-105. (PMID: 32251918) |
| معلومات مُعتمدة: | 2022ZYYL13 Clinical comprehensive evaluation of drugs special research project of Zhejiang Pharmaceutical Association |
| فهرسة مساهمة: | Keywords: Adverse drug reaction; Dose increasing; Lurasidone; Rash |
| المشرفين على المادة: | O0P4I5851I (Lurasidone Hydrochloride) 0 (Antipsychotic Agents) |
| تواريخ الأحداث: | Date Created: 20240708 Date Completed: 20240708 Latest Revision: 20240711 |
| رمز التحديث: | 20240711 |
| مُعرف محوري في PubMed: | PMC11229191 |
| DOI: | 10.1186/s12888-024-05668-5 |
| PMID: | 38977949 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1471-244X |
|---|---|
| DOI: | 10.1186/s12888-024-05668-5 |